Choreo LLC’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$889K Buy
60,940
+463
+0.8% +$4.47K 0.01% 700
2026
Q1
$449K Sell
60,477
-985
-2% -$10.4K 0.01% 1001
2025
Q4
$752K Buy
61,462
+1,313
+2% +$14.2K 0.01% 732
2025
Q3
$464K Buy
60,149
+23,377
+64% +$164K 0.01% 953
2025
Q2
$269K Sell
36,772
-3,199
-8% -$25.8K ﹤0.01% 1250
2025
Q1
$379K Sell
39,971
-1,978
-5% -$24.7K 0.01% 982
2024
Q4
$710K Sell
41,949
-19
-0% -$295 0.01% 713
2024
Q3
$580K Buy
41,968
+1,193
+3% +$18.7K 0.01% 830
2024
Q2
$568K Buy
+40,775
New +$578K 0.01% 758

Other funds holding NEO

Choreo LLC's NEO Position: Q2 2026 in Review

Choreo LLC increased its NeoGenomics (NEO) stake by 0.77% in Q2 2026, buying an estimated $4.47K and bringing the position to 60,940 shares worth $889K. The position accounts for 0.01% of the portfolio, ranked #700.

Choreo LLC first reported a position in NEO in Q2 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Choreo LLC held 60,940 shares of NeoGenomics worth $889K as of Q2 2026.
  • Choreo LLC bought 463 NeoGenomics shares in Q2 2026, an estimated $4.47K.
  • NeoGenomics made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #700 holding.
  • Choreo LLC first reported a position in NeoGenomics in Q2 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.